Ge
GenNBio
Seoul KRFounded 201830 employees
Private CapbiotechPrivateOncology
Platform: AI Neo-Ag
Market Cap
N/A
All Drugs
2
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gozeosocimab | GEN-2733 | Phase 1/2 | 2 | FLT3 | SCDSchizophrenia | ||
| Teraosocimab | GEN-5320 | Phase 3 | 4 | CDK4/6 | MigraineSLE |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)